-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
This morning, Olin Biologics was officially listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange
.
It is reported that the company's IPO adopted the fifth set of listing standards on the Science and Technology Innovation Board, the sponsor (lead underwriter) is Yingda Securities, and the issue price is 9.
The prospectus shows that currently, the company's product pipeline contains 13 products
.
Among them, three products have been launched on the market, namely the adsorbed tetanus vaccine, the Haemophilus influenzae type b conjugate vaccine, and the group A group C meningococcal polysaccharide conjugate vaccine